Evansville-based Berry Global Group Inc. (NYSE: BERY) says it is investing $70 million to keep up with the growing demand for medical wipes.
The company says it will launch a new production line in the U.S. to increase production capacity of its wipe substrate material.
Berry says demand was already on the rise prior to the pandemic, growing 6% from 2014 to 2019. The company says demand for disinfectant wipes has likely made a permanent shift, which is why Berry is making the investment.
The company says this investment is complementary to its existing portfolio and features Berry’s proprietary Spinlace technology, a nonwoven material that can be used in wipes, filtration and healthcare applications.